Owens & Minor is focused on paying down debt and rethinking how it builds momentum in its “pure-play” Patient Direct business ...

On Monday, Owens & Minor Inc. (NYSE:OMI) reported adjusted earnings for the second quarter that missed analyst projections as ...

Owens & Minor says it is in the final stages of selling its Products & Healthcare Services segment, says CEO Ed Pesicka.

Owens & Minor, Inc. faces financial distress with a 70% stock drop, weak margins, and strategic missteps. Click here to find out why OMI stock is a Hold.

Citigroup analyst Daniel Grosslight maintained Owens & Minor with a Buy and lowered the price target from $11 to $7. Baird ...

Shares of Owens & Minor (NYSE:OMI) fell on Monday after the company's 2025 outlook failed to meet analysts' expectation, while also missing Q2 earnings estimates. The company said it expects its full ...

Medical supply and logistics company Owens & Minor (NYSE:OMI) will be announcing earnings results this Monday before market ...

Owens & Minor Inc (OMI) reports a 3.3% revenue increase while focusing on strategic divestitures and overcoming supply chain ...

Owens & Minor missed EPS estimates in Q2, but sales and EBITDA grew as it advanced plans to sell one of its segments.

Owens & Minor (NYSE:OMI) is set to give its latest quarterly earnings report on Thursday, 2025-05-08. Here's what investors need to know before the announcement. Analysts estimate that Owens ...

Coliseum Capital, a ten-percent owner of Owens & Minor INC/VA/ (NYSE:OMI), has recently purchased shares of the company worth approximately $8.1 million. These purchases, executed between August 12 ...